These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7528427)
1. The UroLume endoprosthesis: a summary of the European and North American experience. Oesterling JE Prog Clin Biol Res; 1994; 386():561-75. PubMed ID: 7528427 [TBL] [Abstract][Full Text] [Related]
3. [Use of UroLume as an alternative to the treatment of recurrent stenosis of bulbar urethra and obstructive prostatic hyperplasia in patients with high surgical risk]. Serrano-Brambila EA; Camacho-Carvajal JC; Moreno-Aranda J; Martínez-Sánchez R Gac Med Mex; 2003; 139(5):435-48. PubMed ID: 14635562 [TBL] [Abstract][Full Text] [Related]
4. Urologic applications of a permanent, epithelializing urethral endoprosthesis. Oesterling JE Urology; 1993 Jan; 41(1 Suppl):10-8. PubMed ID: 7678360 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation. Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567 [TBL] [Abstract][Full Text] [Related]
6. Reversible clinical outcome after sphincter stent removal. Chancellor MB; Rivas DA; Watanabe T; Bennett JK; Foote JE; Green BG; Killorin EW; MacMillan R J Urol; 1996 Jun; 155(6):1992-4. PubMed ID: 8618306 [TBL] [Abstract][Full Text] [Related]
11. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859 [TBL] [Abstract][Full Text] [Related]
12. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter]. Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950 [TBL] [Abstract][Full Text] [Related]
13. Transurethral vaporization of the prostate in the treatment of bladder outlet obstruction at two university hospitals. Gerber GS; Jahoda A; Bales GT; Albala DM Tech Urol; 1997; 3(1):25-9. PubMed ID: 9170221 [TBL] [Abstract][Full Text] [Related]
14. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group. Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091 [TBL] [Abstract][Full Text] [Related]
15. Urolume urethral wallstent in the treatment of detrusor sphincter dyssynergia. Juma S; Niku SD; Brodak PP; Joseph AC Paraplegia; 1994 Sep; 32(9):616-21. PubMed ID: 7997341 [TBL] [Abstract][Full Text] [Related]
16. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. Ghalayini IF; Al-Ghazo MA; Pickard RS BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128 [TBL] [Abstract][Full Text] [Related]
17. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience. Kahn SA; Alphonse P; Tewari A; Narayan P J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934 [TBL] [Abstract][Full Text] [Related]
18. Role of permanent stents. Badlani GH J Endourol; 1997 Dec; 11(6):473-5. PubMed ID: 9440859 [TBL] [Abstract][Full Text] [Related]